Breaking News

Avaxia Names Research VP

March 26, 2013

Hartman brings 20 years of R&D experience

Deborah S. Hartman, Ph.D. has been appointed vice president of Research at Avaxia Biologics, Inc. Dr. Hartman is a scientist and senior executive with more than 20 years of experience leading international pharmaceutical R&D functions in multiple therapeutic areas.
Prior to joining the company, Dr. Hartman held a number of executive level roles at AstraZeneca, most recently as vice president of Projects in Innovative Medicines. Other positions included vice president of Respiratory & Inflammation Research UK and vice president of Lead Generation DECS, a global science and technology group supporting early-stage projects in eight disease areas across 12 R&D sites. Prior to joining AZ, Dr. Hartman spent seven years at Hoffmann-La Roche in Basel, Switzerland, as a project leader and principal scientist in nervous system diseases.
Barbara S. Fox, Ph.D., chief executive officer of Avaxia, said, “Debbie has a strong track record of delivering new drugs into the clinic and managing early clinical development. In addition to leading research efforts on AVX-470, Debbie will expand our pipeline of gut-targeted oral antibody therapeutics through internal efforts and external collaborations. I would also like to thank Dan Tracey, our former vice president, Research, for his many contributions to Avaxia and to wish him well in his retirement. We are grateful that Dan will continue to support Avaxia as a consultant.”
  • When Quality Meets Confidence

    When Quality Meets Confidence

    Dr. Fadia AlKhalil, Vice President of Global Business Development for Laboratory Services, SGS ||November 9, 2016
    A look at global account management for R&D outsourcing

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus